logo
logo

Stemregen® Names Ryan Riley As Chief Executive Officer, Christian Drapeau As Chief Science Officer

Apr 25, 2024over 1 year ago

Position

Chief Science Officer

Company

STEMREGEN®

Christian Drapeau
AustinBiotechnologyHealth Care

Description

STEMREGEN® announces leadership team changes aligned around the company's business objectives and growth trajectory. Christian Drapeau, the neurophysiology scientist and founder, will become Chief Science Officer to focus on the brand's cutting-edge stem cell research. Ryan Riley, former CEO of Microbe Formulas and CellCore Biosciences, will succeed Drapeau as CEO.

Company Information

Company

STEMREGEN®

Location

Austin, Texas, United States

About

Stemregen creates supplements containing plant extracts sourced from around the globe that have been documented to naturally increase the number of circulating stem cells in the human body. Its core product includes Stemberry™; a sea buckthorn berry extract, Stemaloe™; a proprietary complex with aloe from a unique source, and other ingredients. One serving of two capsules was documented to trigger the release of an average of 10 million additional stem cells from bone marrow to help support the body's innate repair system, paving the way for healthy aging with optimal health and longevity.

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months